Search results for: Robert Ord

Items from 1 to 17 out of 17 results

article

Oropharyngeal cancer as a driver of racial outcome disparities in squamous cell carcinoma of the head and neck: 10‐year experience at the University of Maryland Greenebaum Cancer Center

Dan P. Zandberg, Sandy Liu, Olga Goloubeva, Robert Ord, more

Background Racial outcome disparities have been observed in head and neck squamous cell carcinoma (HNSCC) with diminished survival for black patients compared with white patients. Methods We retrospectively analyzed 1318 patients with primary HNSCC treated at the University of Maryland Greenebaum Cancer Center (UMGCC) from 2000 to 2010. Results Of all the patients, 65.9% were white, 30.7% were...

article

A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)

Dan P. Zandberg, Sandra Rollins, Olga Goloubeva, Robert E. Morales, more

Cancer Immunology, Immunotherapy > 2015 > 64 > 3 > 367-379

Background We conducted a phase I dose escalation study to evaluate the safety and immunologic response to peptide immunomodulatory vaccines GL-0810 (HPV16) and GL-0817 (MAGE-A3) in HPV16 and MAGE-A3-positive RM–SCCHN patients, respectively. Methods Three dose levels (500, 1,000, and 1,500 µg) of GL-0810 or GL-0817 with adjuvants Montanide (1.2 ml) and GM-CSF (100 µg/m2) were administered...

article

Multiple Primary Squamous Cell Carcinomas of the Oral Cavity

Mohammed Qaisi, John Vorrasi, Joshua Lubek, Robert Ord

Journal of Oral and Maxillofacial Surgery > 2014 > 72 > 8 > 1511-1516

There is a subset of patients who develop multiple primary squamous cell carcinomas (SCCs) of the oral cavity. The aim of this study was to better characterize this group of patients and determine whether there are any associated risk factors.This is a retrospective review of all patients treated for oral SCCs at the University of Maryland Department of Oral and Maxillofacial Surgery from November...

article

Microvascular tissue transfer in the management of advanced osteoradionecrosis

Mohammed Qaisi, John Vorrasi, Donita Dyalram-Silverberg, Robert Ord, more

Oral Oncology > 2013 > 49 > Supplement 1 > S84

The purpose of this study is to evaluate the outcomes of the use of microvascular free flaps (MVFF’s) in the management of advanced stage III osteoradionecrosis (ORN) that fails conservative management.This is a retrospective review of all patients treated for ORN with radical resection and microvascular reconstruction at the University of Maryland department of oral & maxillofacial surgery between...

article

Nasal Chondromesenchymal Hamartoma: Report of a Case Presenting With Intraoral Signs

Yeong Cheol Cho, Iel Yong Sung, Jang Ho Son, Robert Ord

Journal of Oral and Maxillofacial Surgery > 2013 > 71 > 1 > 72-76

article

Venous Anastomoses Using Microvascular Coupler in Free Flap Head and Neck Reconstruction

Tao Zhang, Joshua Lubek, Andrew Salama, John Caccamese, more

Journal of Oral and Maxillofacial Surgery > 2012 > 70 > 4 > 992-996

This study is a retrospective review of the experience using the venous coupler for head and neck reconstruction over a 3-year period at the University of Maryland Medical Center, Department of Oral and Maxillofacial Surgery. One hundred seventy-eight consecutive cases of microvascular free flaps between May 2007 and September 2010 were retrospectively reviewed. Data were collected by demographic...

article

Phase II Study Evaluating the Addition of Cetuximab to the Concurrent Delivery of Weekly Carboplatin, Paclitaxel, and Daily Radiotherapy for Patients With Locally Advanced Squamous Cell Carcinomas of the Head and Neck

Mohan Suntharalingam, Young Kwok, Olga Goloubeva, Arti Parekh, more

International Journal of Radiation Oncology, Biology, Physics > 2012 > 82 > 5 > 1845-1850

To report the mature data of a prospective Phase II trial designed to evaluate the efficacy of an epidermal growth factor receptor inhibitor cetuximab (CTX) added to the concurrent therapy of weekly paclitaxel/carboplatin (PC) and daily radiation therapy (RT).From 2005 to 2009, a total of 43 patients were enrolled in the study. The median follow-up was 31 months (range, 9–59 months). All patients...

article

Oral maxillary squamous carcinoma: An indication for neck dissection in the clinically negative neck

David M. Montes, Eric R. Carlson, Rui Fernandes, G. E. Ghali, more

Head & Neck > 33 > 11 > 1581 - 1585

BackgroundThis multicenter study was undertaken to characterize the metastatic behavior of oral maxillary squamous carcinoma and to determine the role of selective neck dissection. MethodsA retrospective, multicenter study of patients surgically treated for oral maxillary squamous carcinoma was completed. Data collected included primary tumor location, cervical lymph node status, and neck failure...

article

Impact of early percutaneous endoscopic gastrostomy tube placement on nutritional status and hospitalization in patients with head and neck cancer receiving definitive chemoradiation therapy

Charles E. Rutter, Susannah Yovino, Rodney Taylor, Jeffrey Wolf, more

Head & Neck > 33 > 10 > 1441 - 1447

BackgroundThis study analyzed the impact of timing of percutaneous endoscopic gastrostomy (PEG) tube placement on clinical endpoints in patients undergoing concurrent chemoradiation therapy (CRT). MethodsIn all, 111 patients who underwent CRT for locally advanced squamous cell carcinoma of the head and neck (SCCHN) were retrospectively analyzed to determine the effect of timing of PEG placement on...

article

Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy

Susannah Yovino, Kathleen Settle, Rodney Taylor, Jeffrey Wolf, more

Head & Neck > 32 > 1 > 46 - 52

Background.The role of adjuvant neck dissection in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) who obtain complete clinical and radiologic response following definitive chemoradiation treatment is controversial. Methods.Patterns of failure among 120 patients with locally advanced SCCHN, all with node‐positive disease, treated with concurrent chemoradiation,...

article

The pathology and management of aggressive odontogenic tumours

Robert Ord

British Journal of Oral & Maxillofacial Surgery > 2009 > 47 > 4 > 340

article

Trends and management of paediatric ameloblastoma

Andrew Salama, Shawn McClure, Robert Ord

British Journal of Oral & Maxillofacial Surgery > 2007 > 45 > 7 > e45

article

Is bone resection essential for low/intermediate grade mucoepidermoid carinomas of the palate?

Robert Ord

British Journal of Oral & Maxillofacial Surgery > 2007 > 45 > 7 > e40

article

Comprehensive management of ballistic injuries in an urban America trauma unit

Domenick Coletti, John Caccamese, Robert Ord

British Journal of Oral & Maxillofacial Surgery > 2007 > 45 > 7 > e33

article

A Non-Lip-Splitting Double Mandibular Osteotomy Technique Applied for Resection of Tumors in the Parapharyngeal and Pterygomandibular Spaces

Antonia Kolokythas, Rui P. Fernandes, Robert Ord

Journal of Oral and Maxillofacial Surgery > 2007 > 65 > 3 > 566-569

article

Metastasis to the Percutaneous Endoscopic Gastrostomy Site in the Patient With Head and Neck Cancer: A Case Report and Review of the Literature

Domenick Coletti, Thomas Genuit, Robert Ord, Stephen Engroff

Journal of Oral and Maxillofacial Surgery > 2006 > 64 > 7 > 1149-1157

article

The evaluation of amifostine for mucosal protection in patients with advanced loco-regional Squamous Cell Carcinomas of the Head and Neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily Radiotherapy (RT)

Mohan Suntharalingam, Jerry Jaboin, Rodney Taylor, Jeffrey Wolf, more

Seminars in Oncology > 2004 > 31 > Supplement 18 > 2-7

Concurrent chemotherapy and radiation has improved the outcome for patients presenting with locally advanced squamous cell carcinomas of the head and neck (SCCHN). These improvements have come at a cost of increased treatment-related toxicities. We previously reported the results of a phase II trial examining the role of concurrent carboplatin, paclitaxel, and daily radiotherapy (RT) in SCCHN. In...

Filter options

Publication date

Set your own date range

INFONA - science communication portal

Search results for: Robert Ord

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options